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Abstract: Microcystins (MCs) are the most commonly occurring hepatotoxins produced by cyanobacteria. The inhibition of 
PP2A is widely assumed as the principal mechanism of toxicity of MCs, however recently it has been found that MC 
modulates PP2A activity not only by direct inhibition of its activity, but also by regulating its expression. Nevertheless the 
mechanisms of toxicity of MCs seem to be more complex to interpret than expected. The induction of some cellular-
molecular mechanisms appears to be biphasic in time and concentration of MC and in most cases related with the 
intracellular ROS generation. These intracellular ROS levels cause oxidative stress which leads to changes in several 
markers of MC-LR-induced oxidative stress ultimately resulting in apoptosis or cell damage and also genotoxicity. MCs 
can also induce severe changes in the cytoskeleton elements: microfilaments, intermediate filaments and microtubules, 
which results in changes in the cytoskeleton architecture and cell viability. There are also indications that there are second 
messengers involved in MC-LR mediated cytotoxicity and apoptosis. Different congeners of these toxins induce different 
degrees of responses in the cell, assumed to be related with the capacity of toxin internalization, affinity towards PP1 and 
PP2A, and the ability to cause oxidative stress. MCs have also been implicated in neurotoxicity and in damages in 
reproductive organs. The regulation of transcription factors and proto-oncogenes by MC is the mode of action of MCs 
tumor promotion. This review summarizes mainly the findings from the last five years about the molecular mechanisms 
behind MC toxicity in animal cells. 
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1. INTRODUCTION 
Microcystins (MCs) are toxic metabolites produced by several cyanobacterial (blue green algae) widely distributed in the 
environment. The genera usually associated with the production of these cyanotoxins are Microcystis, Anabaena, Nostoc, 
Planktothrix, Anabaenopsis, Hapalosiphon, and Nodularia. Over 80 structural congeners with a size between 909–1115 Da 
characterize this group of cyclic heptapeptides [1,2]. The general structure of MCs is cyclo(-D-Ala1-L-X2-D-erythro-β-
methylAsp3-L-Z4-Adda5-D-Glu6-N-methyldehydro-Ala7) being X and Z variable L-amino acid residues that differentiate 
several of MC congeners and Adda the unique D-amino acid 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic 
acid [3,4]. In addition amino acid modifications in the cyclic heptapeptide backbone characterize other MC congeners. Within 
this group the toxin congeners, MC-LR, -RR, and -YR are considered the most toxic and abundant species [5,6]. 
MCs have received increasing attention in the past decades as a public health threat, to this awareness contributed the reports of 
human and animal intoxications and the increased evidences that MCs may cause serious health problems, such as various liver 
diseases, including primary liver cancer, hepatitis, and liver injury [7,8]. The oral intake is probably the major route of exposure 
to MCs in Humans. The tumor promoting potential of this toxin was related with the chronic exposure to low doses in drinking 
water [9]. 
The observations that MCs are potent inhibitors of serine/threonine-specific protein phosphatases (PPs), especially PP1 and 
PP2A [10-12], led to the widely accepted hypothesis that this molecular interaction is the main toxic mechanism of MCs. This 
mechanism is conserved among MC congeners, with different congeners showing comparable inhibitory capacity of PP1 and 
PP2A in vitro [13,14]. 
The toxicity of MCs is related with the rate of cell internalization. The molecular size render these molecules apparently 
incapable of crossing cell membranes via passive diffusion, therefore it is generally accepted that MCs enter the cells by active 
transport through specific transporters, the organic anion-transporting polypeptides (OATPs) [15,16].  It also has been found 
that MC-LR can produce a large amount of reactive oxygen species (ROS) in both in vitro and in vivo models as part of the 
toxicological action [17,18]. Following PP inhibition and oxidative stress a subsequent cascade of molecular events and 
signaling pathways are triggered resulting in lipid peroxidation, cytoskeletal disorganization, collapse of the cytoskeleton, 
increasing in levels of ROS, mitochondrial permeability transition, Cytochrome c release, and apoptosis [7]. The proteins p53, 
Bcl-2 and Bax were early associated to the regulation of MC-LR induced apoptosis [19]. 
However, the detailed toxicological mechanism involved in over-production of ROS remains unclear. Evidences suggest that 
the expression of p53, Bcl-2 and Bax are thought to be involved in the regulation of MC-LR induced apoptosis [19] but more 
functional studies are required to elucidate the exact mechanisms underlying the apoptosis-inducing potential of this toxin. 
Novel evidences show the complex regulation of PP2A protein during the interaction with MC-LR, thereby leaving open the 
elucidation of the exact role of the protein in the toxic action of MCs in in vivo systems. Recent studies also have pointed out 
nitric oxide (NO), an important cellular secondary messenger influencing the development, progression and treatment of 
diseases, to participate in MC toxicity.  
In this work we revised recent information of MCs toxicity molecular mechanisms in animal cells, using data from in vitro 
studies using e.g. cell lines, as well as, in vivo studies, namely using rats or fish, thereby providing an overview of the current 
state of the art in MC toxicity, which could facilitate the identification of novel and priority objectives of research. The 
genotoxicity of MCs is a well-studied topic which deserves a separate review and for this reason was not overviewed here.  
 
2. MODE OF ACTION OF MICROCYSTINS 
 
2.0 Cellular uptake of MCs 
Microcystins (MCs) are molecules of relatively high molecular mass (900–1100 Da) [1], nevertheless their potent toxic action 
may denote a significant cellular internalization. Initial studies of cellular up-take with radiolabeled derivative of MC-LR have 
pointed out the cellular specificity of the transport in hepatocytes, moreover by means of the use of bile acid transporter 
inhibitors, the requirement of this active system for MC to enter the cells became evident [15]. The elucidation of the exact 
mechanism of MC transport, which involves different members of organic anion transporting polypeptides (OATPs), was later 
achieved with the Xenopus laevis oocyte expression system [20].  
The specificity of this transport determines the main cellular targets of this group of toxins and likely the rate of uptake of the 
toxin. More recently Fisher and co-workers [21] demonstrated that HEK293 (Human Embryonic Kidney 293) cells stably 
expressing recombinant human OATP1B1/SLCO1B1 and OATP1B3/SLCO1B3 showed an increased susceptibility to MCs 
comparatively to control vector expressing cells. In this system and in primary hepatocytes, the cytotoxicity differences 
observed in the congeners MC-LW and -LF comparatively to MC-LR and MC-RR, were attributed to selective transport in the 
plasma membrane. Of notice is that all MC congeners show comparable PP-inhibiting capabilities. The proof of concept of the 
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role of OATPs in MCs toxicity was also achieved with the assessment of cytotoxicity in cells differentially expressing members 
of this family of transporters. Cells expressing lower OATPs, like HepG2 (human liver carcinoma) and Jurkat T (T 
lymphocyte) cells, showed no sensitivity to MC-LR as compared to primary hepatocytes. However this response could be 
reverted with facilitated delivery of MC-LR (e.g. by inducing endocytosis) resulting in a marked enhancement of HepG2 O2 
consumption and inhibition of Jurkat T O2 consumption at concentrations above 0.1 nM MC-LR. In this study the cellular 
respiration was the most sensitive test to low MC-LR, as compared to cell viability, total cellular ATP, extracellular 
acidification, ROS formation, or protein phosphorylation [22]. Following these results the authors proposed that MC-LR acts as 
an uncoupler of the Electron Transport Chain (ETC) affecting complex I functioning and increasing mitochondrial O2 
consumption.  
On the other hand the toxicity observed in cell types that do not express OATPs, such as epidermal cells, after prolonged 
incubation time with MCs [23], could be associated to a probable internalization by cell membrane diffusion of MCs. 
 
2.1 Inhibition of protein phosphatases 
Many cellular processes are regulated by reversible phosphorylation, a mechanism that is controlled by protein kinases and 
protein phosphatases, where they have opposing roles. Proteins are phosphorylated predominantly on Ser and Thr residues due 
to the activity of protein phosphatases types 1 (PP1) and 2A (PP2A). The discovery that MCs are potent inhibitors of PPs dates 
back to 1990 from the work of MacKintosh and co-workers that demonstrated in vitro inhibition of protein phosphatases 1 and 
2A from both mammals and higher plants [24]. Since then the exact nature of interaction with PP1 and PP2A has been 
revealed, as well as the crystal structure of the complex. In synthesis, the interaction of MC-LR with PP1 and PP2A was 
reported as a two-step mechanism where the toxin first binds to the enzyme inactivating it and subsequently forms covalent 
adducts during prolonged reaction-time [24,25]. The interaction occurs between the hydrophobic groove, C-terminal groove 
and the catalytic site of PP-1c and the Glu, MeAsp and ADDA residues of the toxin [26]. The covalent binding with PP2A 
occurs between the Sγ atom of Cys269 of the enzyme and the terminal carbon atom of the Mdha side chain of the toxin [27]. 
Early in vitro studies using the catalytic subunits of PP1 and PP2A enabled to determine IC50 values of 0.04 nM for PP2A and 
1.7 nM for  PP1 [28]. Moreover early studies pointed nuclear PP2A to be the primary target of MC-LR after acute exposure, 
followed by cytoplasmic PP2A [29]. Inhibition of these enzymes disrupts the balance between the states of phosphorylation and 
dephosphorylation, leading to hyperphosphorylation of proteins involved in the dynamic organization of the cytoskeleton 
which, in turn, induces changes in the structure of hepatocytes. 
 
More recent evidences suggest that MC modulates PP2A activity not only by direct inhibition of PP2A activity, but also by 
regulating its expression. Some studies using human cellular lines (human amniotic epithelial (FL) cells) and human hepatoma 
cells (Huh7) show that MC-LR increases PP2A phosphatase activity through upregulating the mRNA and protein levels of 
PP2A [30,31]. When analyzing the effects of MCs on phosphoprotein phosphatases gene expression in the freshwater clam 
Corbicula fluminea, it was verified that there is a significant induction of PP2 gene expression, opposing to the lack of changes 
in the PP1 and PP4 gene expression [32]. Hence there is the possibility that organisms respond to PP2A inhibition by 
synthesizing more enzyme to replace the activity. 
Despite the advances in the elucidation of MC mediated PP1A and PP2A inhibition, the mechanism is not fully disclosed. 
Indeed PP2A are holoenzymes composed of a dimeric core with structural A (PP2A/A) and catalytic C (PP2A/C) subunits 
which are regulated by several regulatory B subunits and by post-translational modifications (PTMs). Each of the A and C 
subunits are coded by two genes in mammalian cells, whereas B subunits are coded by four subfamilies of genes, hence 
conferring PP2A distinct functions and characteristics [27,33]. This opens the hypothesis of a possible differential affinity of 
MCs to the holoenzymes determined by protein sequence, PTMs and the functions of the variable regulatory subunits. In this 
respect the interaction of MCs to the PP2A holoenzyme could define a new mode of interpretation of its toxicity. MC-LR has 
shown to induce a dual response in PP2A. At low concentration the toxin stimulates, rather than inhibits, PP2A activity of 
human embryonic kidney HEK293 cells [34]. Immunoprecipitation and immunofluorescence assays performed by the 
researchers revealed that the catalytic subunit and a regulatory subunit of PP2A, termed α4, dissociate from inactive complex 
upon MC-LR exposure, which could have originated the gain of activity of the catalytic subunit in the cellular inactive protein 
complex pool [34]. This mechanism was suggested to compensate the inhibition induced by MC-LR. However at high 
concentration the toxin decreases PP2A activity of HEK293 cells, as a result of a superior inhibition reaction to the 
compensatory effect. PP2A inhibition was followed by the destabilization of HEK293 cells cytoskeleton architecture, 
detachment to extracellular matrix and further anoikis [34]. The results place α4 not only in the heart of PP2A activity 
regulation but also in mediation of toxicity of MCs. The second messenger ceramide has also been referred to intervene in this 
function (mechanism detailed in section 2.4).  
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2.2 Oxidative stress 
Oxidative stress can be defined as the exposure of the cell or tissue to an excess level of oxidants, particularly to free radicals, 
such as peroxide, superoxide or hydroxyl radicals, which are usually referred as reactive oxygen species (ROS). Oxidative 
stress occurs either due to an overproduction of ROS or to a decrease of the cellular antioxidant levels [35]. Oxidative stress has 
been regarded, in parallel with PP2A inhibition, as one of the major pathways of MCs cytotoxicity. MC-LR mediated oxidative 
stress was first reported in primary cultures of rat hepatocytes [36] and subsequently verified in other in vitro systems [37-39] 
and in vivo [40-42]. Previous studies indicated that oxidative damage is dose-dependent [36,40] and is characterized by 
alterations in several markers of cytotoxicity (lactate dehydrogenase leakage), lipid peroxidation (e.g. malondialdehyde), ROS 
and antioxidant enzymes [35,43]. Oxidative stress is intrinsically related with mitochondria metabolism and can conduct to cell 
death by necrosis or apoptosis and to genotoxicity. Earlier evidences led to the suggestion that ROS formation is a consequence 
of mitochondrial permeability transition (MPT) and loss of mitochondrial membrane potential (MMP) mediated by cellular 
Ca2+ levels [44,45]. MPT subsequently triggers the release of apoptotic factors from mitochondria, such as cytochrome c, Bax 
and Bid proteins and leads to cell death and cytotoxicity [41,44]. 
In the mitochondria-dependent apoptotic pathway the c-Jun N-terminal protein kinase (JNK) plays an important regulatory role. 
The earlier findings showed that MC-LR induces the activation of JNK [46]. This event affects some crucial enzymes of energy 
metabolism and leads to mitochondria dysfunction induced by MC-LR. Activity of JNK may, in this way, contribute 
significantly to hepatocyte apoptosis and oxidative liver injury by MC-LR [46].  
Recent studies have once again pointed out the increase of intracellular ROS as a main marker of exposure to MC-LR [47,48]. 
ROS generation has biphasic time, is toxin-concentration dependent [49] and is related to impairment of mitochondrial 
respiratory chain and oxidative phosphorylation system [50]. It was also recently shown that the ability to cause oxidative stress 
may underlie the differential toxicity observed between chemical variants, MC-LR and MC-RR. The toxic action of the two 
variants in intestinal cells was linked to oxidative stress and to the expression of pro-inflammatory IL-6 and IL-8 proteins, IL-8 
accumulation being more dependent on the MC variant [51]. As to shed more light on the role of oxidative stress on the toxicity 
induced by MCs, this biochemical process was investigated with and without the effect of the antioxidants N-acetyl-cysteine 
(NAC) and buthionine sulfoximine (BSO), in the liver of the model fish Cyprinus carpio L. The action of MC-LR is followed 
by a series of molecular events linked with oxidative stress, such as the increase of hydroxyl radical (•OH) and the subsequent 
induced expression of apoptosis-related genes, including p38, JNKa, and bcl-2. Strikingly NAC provided significant protection 
to the cytoskeleton, thereby evidencing that oxidative stress is a key process in the mode of action of MCs and that the 
toxicological outcomes could be partially counteracted by protecting the tissues from oxidative stress [52]. 
In the same line of research the role of the nuclear factor erythroid 2-related factor 2 (Nrf2) on the oxidative stress mediated 
MC-LA toxicity was investigated in wild type (WT), Nrf2-null and Keap1-HKO knock-down mice [53]. Nrf2 has been 
considered an important defense mechanism to oxidative and electrophilic stresses in the liver, by regulating the expression of a 
conjunct of antioxidant proteins [54,55]. In the cell Nrf2 is regulated by degradation via ubiquitin system and involving the 
participation of Kelch like-ECH-associated protein 1 (Keap1) and Cullin 3 [54,55]. Under oxidative/electrophilic stress Keap1 
activity is disrupted, stopping the degradation of Nrf2. The transcription factor will then activate the oxidative defense system. 
Lu and co-workers [53] demonstrated that Nrf2 is also involved in MC-LA toxicity and mediates the cellular action of the 
toxin. The authors reported an increase of Nrf2 and Nqo1 mRNAs and proteins in Keap1-HKO knock-down mice at 
constitutive levels and after MC challenge. Moreover MC-LA markedly depleted liver GSH by 60–70% in Nrf2-null and WT 
mice but only 35% in Keap1-HKO knock-down mice. The mRNAs of GSH conjugation and peroxide reduction enzymes, such 
as Gsta1, Gsta4, Gstm, and Gpx2 were higher in livers of Keap1-HKO mice, together with higher expression of the rate-
limiting enzyme for GSH synthesis (Gclc) [53]. 
 
2.3 Cytotoxicity 
There are three cytoskeleton structural elements: microfilaments (MFs), intermediate filaments (IF) and microtubules (MT). It 
had been previously demonstrated that the exposure to MC induces several cystoskeletal alterations, particularly the 
hyperphosphorylation of cystoskeletal proteins, such as cytokeratins, through PP1 and PP2A inhibition which leads to 
reorganization, disassembly, and consequently to disruption of cellular architecture [11,56]. Gácsi et al. [57] tested MC-LR 
toxic effects in a concentration and time dependent manner and verified apoptotic shrinkage in cells treated with 5–50 µM MC-
LR for 24 h which displayed a reduction on the number of cells presenting normal actin, the degradation of microfilament 
mesh, and a concentration dependent depolymerization of microtubules [57]. Also, the inhibition of PP2A could lead to the 
activation of mitogen-activated protein kinases (MAPKs) including ERK1/2, JNK, and p38, which subsequently participate to 
apoptosis [58].  
More recently, Liang et al. [30] observed that exposure to MC-LR impairs the ability of B55-containing PP2A to bind to 
tyrosinated tubulin, and suggested that PP2A is involved in the MT destabilization induced by MC-LR. Moreover, Huang et al. 
[48] showed aggregation and collapse of microfilaments (MFs) and microtubules (MTs) in CIK (Ctenopharyngodon idellus 
kidney) cells exposed to MC-LR and also loss of some cytoskeleton structure. The authors also observed transcriptional 
changes of cytoskeletal genes (β-actin, lc3a, and keratin), that are probably related with cytoskeleton structure damage [48]. 
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These findings raised the hypothesis that oxidative stress and cytoskeletal disruption are interconnected and both contribute to 
apoptosis and renal toxicity induced by MCs [48]. Furthermore, mRNA and protein levels of microfilament associated proteins 
ezrin, vasodilator stimulated phosphoprotein (VASP), actin-related protein (ARP) 2/3 and cofilin remained unchanged in 
normal human liver HL7702 cells [59]. However, the actin filaments lost their characteristic filamentous organization after 
treatment with MC-LR, revealing increased actin depolymerization [59]. Major IF proteins, such as keratin 18, vimentin and 
lamin A/C maintain their mRNA and protein levels after exposure to MC-LR, despite the accumulation of IFs around the 
nucleus, which led to the formation of dense bundles [60]. MC-LR doses 10 times above the guideline value (1µg L-1) led to a 
decrease of cell proliferation and an increase in apoptosis and cell cycle arrest [60].  
Indeed MCs can induce apoptosis in a variety of cell types. Apoptosis is a mechanism used by cells and tissues in response to 
various toxic compounds, characterized by distinct morphological features such as cell shrinkage, condensation of nuclear 
chromatin and of the cytoplasm, detachment of the cells from surrounding cells, plasma membrane blebbing, oligonucleosomal 
DNA fragmentation, externalization of membrane phosphatidylserine and ultimately the breakdown of the cell into smaller 
units (apoptotic bodies) [35,61]. Apoptosis may be induced by both intrinsic and extrinsic pathways. The extrinsic pathway 
occurs when appropriate exogenous mediators or ligands bind to pro-apoptosis receptors of the target cells to induce apoptosis. 
Fas ligand (FasL) and Fas receptor (Fas) signaling is one of the major extrinsic pathways initiating apoptosis [61]. The 
mechanisms behind the apoptosis induction by MCs have been under investigation. Feng et al. [61] showed that MC-LR 
induced Fas receptor (Fas) and Fas ligand (FasL) expression, at both mRNA and protein levels system, are mediated by nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-B), a known protein complex that functions as a transcription 
factor and plays a fundamental role in the immune response to infection and is involved in the response to several other cellular 
stimuli [62], thus leading to cellular apoptosis in HepG2 cells. In agreement with this the severe stress effects and apoptosis in 
the rat insulinoma cell line INS-1 upon chronic exposure to MC were shown to be correlated with the selective activation of 
NF-κB [63]. 
There are also evidences that MCLR exerts its hepatotoxicity through MAPK pathway activation, leading to the 
hyperphosphorylation of IF proteins, namely p38, ezrin and ERK1/2 in a concentration-dependent manner [59,60]. The 
activation of p38-MAPK revealed to be biphasic in time and concentration and related with the intracellular ROS generation 
[49]. This mechanism resulted in changes in the cytoskeleton architecture and cell viability. 
It has also been shown that MC variants -LF and -LW, which are more hydrophobic than MC-LR, had more pronounced 
cytotoxic effects on Caco-2 (human colon adenocarcinoma) as compared to MC-LR [64]. Which factors determine the 
differential toxicity of these MC variants need elucidation, nevertheless could be related with the capacity of toxin 
internalization, affinity towards PP1 and PP2A, and the ability to cause oxidative stress.  
Cytotoxic effects have also been observed in immune cells. Rymuszka and Adaszek [65] verified that lower doses of MC-LR 
induced apoptosis in lymphocytes, whereas high toxin concentrations induce necrosis in lymphocytes in a time- and 
concentration-dependent manner. Moreover, the authors observed a re-organization of the actin cytoskeleton in phagocytes, 
followed by cell shrinkage and the disappearance of filopodia. Based on these observations authors suggested that both 
phagocytes and lymphocytes are also MC-LR targets and that disturbances of phagocytosis may impair the balance of the 
immune system [65]. 
The health consequences of the epidermal exposure to MC-LR have been less investigated. However this route of exposure 
could be of concern particularly in cases of skin damage (injury, sunburn) that would enable faster penetration of the toxin, 
leading to contact with the deeper cell layers. To this regard the impact of MC-LR on processes indispensable for normal skin 
function and regeneration, namely, viability, migration and actin cytoskeleton organization of human keratinocytes was 
examined. The results showed that short exposure to MC-LR does not affect proliferation of human skin keratinocytes but it is 
toxic after longer incubation in dose dependent manner. The observed effects ranged from the inhibition of keratinocyte 
migration, cell proliferation, cell enlargement, depolymerization of the F-actin cytoskeleton [23]. 
 
2.4 Second messengers 
As described above calcium was one of the first second messengers to be discovered in the context of MC toxicity. Calcium 
may trigger MC cell death via mitochondria [41,44,45]. However this might not be the only intracellular signaling molecule 
participating in signal transduction during MC exposure. When Krakstad et al. [66] were trying to address the role of calcium 
calmodulin-dependent multifunctional protein kinase II (CaMKII) in MC induced hepatocytes apoptosis, they verified that 
antioxidants (N-acetylcysteine, Tempol or naringin), prevented chromatin condensation when given after the CaMKII-
dependent commitment point. The authors suggested that CaMKII had mediated the accumulation of a second messenger 
belonging to reactive oxygen species [66]. 
Li and coworkers [67] investigated the hypothesis of the involvement of the second messenger ceramide in MC-LR mediated 
cytotoxicity. Ceramide is an important lipid-like second messenger generated by cells and is involved in many cellular 
processes, including PP2A activation, cytoskeleton destabilization and apoptosis [68,69]. The population of PP2A being 
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activated by ceramide is termed ceramide-activated protein phosphatase (CAPP) [70]. CAPP consists of PP2A AC (dimeric) or 
PP2A AC enzymes associated to the regulatory subunits B55α or B56α (trimeric enzymes, PP2A ABC) [71].  
The MC-LR induced toxicity in vivo and in vitro correlated with the generation of ceramide and with other cellular effects 
including inhibition of PP2A, regulation of PP2A subunit protein levels and subcellular localization of PP2A/B55α, contraction 
of the Golgi apparatus, cytoskeleton destabilization and cell detachment [67]. The relevance of ceramide in MC-LR toxicity 
was further evidenced with the utilization of ceramide synthase inhibitor, desipramine, which leads to protection of cells from 
the toxin and cytoskeleton destabilization (polymerization of actin filaments, contraction of microtubulin and vimentin), cell 
detachment, and apoptosis induced by MC-LR [67]. The effects of desipramine in PP2A activity pointed out for a central role 
of ceramide in PP2A regulation, and for the putative involvement of the second messenger in the PP2A activity stimulation or 
inhibition reported in respectively non-toxic and toxic MC-LR concentrations [34,67]. 
Moreover NF-kB, the protein complex that controls transcription of DNA, cytokine production and cell survival, was shown to 
be activated in MC-LR treated apoptotic HepG2 cells [61]. Following NF-kB activation there is an increase of mRNA and 
protein levels of nitric oxide synthase (iNOS). This mechanism is hypothesized to stimulate nitric oxide (NO) production from 
iNOS and to trigger apoptosis in a dose dependent manner [63]. Since the abrogation of NF-kB resulted in the reduction of 
apoptosis it is suggested that NF-kB/iNO signaling pathway play a major role in MC-LR mediated apoptosis [63]. This second 
messenger has been also related with the genotoxic effects in the chronic MC-LR exposure of human-hamster hybrid cells [72]. 
 
2.5 Neurotoxicity 
The neurotoxic action of MC is relatively less characterized compared with the genotoxicity. For this reason it is a mechanism 
less described. There are evidences that MC-LR is also brain-permeable [20,73] thus presenting the possibility that MC-LR 
could exert neurotoxicity. The mechanisms underlying neurotoxicity have been object of some studies. It was observed that 
MC-LR induced hyperphosphorylation of neural microtubule-associated protein tau in a biphasic time and concentration 
dependent manner which correlated with an increase in soluble tau and a decrease in cytoskeleton-associated tau [49,74]. Tau 
proteins are low-molecular-weight microtubule-associated proteins that are abundant in nerve cells. When tau proteins are 
phosphorylated they induce the destabilization of microtubules, compromise axonal transport, and contribute to neuronal 
degeneration [75]. When Meng et al. [74] tried to determine if tau was involved in MC-LR induced reorganization and 
destabilization of the MT structure, they used the Tau-1 antibody, which specifically recognizes the dephosphorylated form of 
tau containing Ser-195, Ser-198, Ser-199, Ser-202 and Thr-205 epitopes. They observed that exposure to MC-LR resulted in a 
decrease in the Tau-1 recognized epitope, especially at 10 µM, where there was a severe PP2A inhibition, suggesting that MC-
LR reduced the dephosphorylation of tau [74]. This suggestion was confirmed when the authors used anti-phospho-tau 
(pSer199/202) antibody, to directly recognize the phosphorylated forms of tau at Ser-199 and Ser-202, and detected a 
progressively enhanced tau phosphorylation in response to increasing MC-LR concentrations [74]. Furthermore, to determine 
whether ROS was involved in MC-LR tau hyperphosphorylation the action of the antioxidants, N-acetylcysteine (NAC) and 
vitamin C was tested [49]. It was verified that the phosphorylation level of tau was effectively recovered due to the inhibition of 
ROS production [49]. Therefore it was suggested that simultaneous alteration of tau phosphorylation at the Ser-199 and Ser-202 
residues, is closely related to previous ROS generation [49,74]. 
Li et al. [76] have shown that MC-LR is accumulated in the hippocampi of Wistar rats upon intraperitoneal injection of the 
toxin. This is followed by impairment of neurological functions assessed with behavioral testing. The mechanisms underlying 
the neurotoxicity of MC-LR may initiate with the inhibition of serine/threonine protein phosphatases (PPs) and hyper-
phosphorylation of proteins such as the neuronal microtubule–associated protein tau and the differential expression of septin 5, 
-internexin, and -synuclein. However global protein profiling demonstrated that MC-LR produce significant alterations at 
the proteome level, affecting proteins involved in cytoskeleton, neurodegenerative disease, oxidative stress, apoptosis, and 
energy metabolism [76]. 
 
2.6 Effects on reproductive organs 
Several recent studies have been showing that MC-LR also exerts toxic effects in reproductive system. The first evidences 
came from the studies from Ding et al. [77] where the reproductive toxicity of Microcystis aeruginosa cell extracts containing 
MCs was tested on male mice. The authors verified a number of alterations on mice testis and epididymides. Later Li et al. [78] 
observed cytotoxicity, oxidative stress and apoptosis of Leydig cells which resulted in decreased testosterone production and 
consequently in reproductive toxicity. 
Overall, the reproductive toxicity is manifested by reduced testosterone levels, testicular atrophy, low sperm motility, and a 
high incidence of sperm abnormalities in a dose- and time-dependent manner [50]. Moreover testis impairment was related to 
ROS and oxidative phosphorylation, cytoskeleton depolymerization and mitochondria dysfunction [79]. The viability of Sertoli 
cells, which play an essential role in the development and maturation of sperm cells, was diminished after treatment with MC-
LR, which induced apoptosis and autophagy [50,80]. Results show that the apoptosis is likely mediated by the expression of the 
transcription factor p53, and by the apoptotic regulators bax, bcl-2 and caspase-3 [81]. Furthermore, Zhou et al. [81] showed 
that MC-LR can increase the number of apoptotic testicular cells, decrease cellular proliferation and disrupt histophatological 
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structures of spermatogenic cells in vivo. Structural changes in testis, tubular diameter and relative weight of testes were also 
decreased. 
The reproductive toxicity induced by MC-LR was also assessed on female mice [82]. Here a reduction of ovary weight was 
observed and attributed to loss of primordial follicle pool provoked by MC-LR exposure. It was also verified that MC-LR could 
accumulate in ovary and directly induce reproductive toxicity [82]. 
 
2.7 Tumor promotion 
Humpage and Falconer [83] have taken the first steps towards the understanding of the mechanisms of the tumor promotion 
activity of MC that was speculated from exposure evidences. Based on these studies and the collected evidences of the tumor 
promoting activity, MC-LR - the most abundant and toxic microcystin congener - was classified by International Agency for 
Research on Cancer (IARC) as a potential carcinogen to humans (class 2B) [84].  
With the studies of Clark et al. [85] the role of p53 in MC-LR induced tumor promotion became evident. Furthermore 
evidences were collected using the monkey kidney-derived cell line Vero-E6 which suggest the involvement of ERK1/2 
pathway [86]. Li et al. [87] also observed that the exposure to MC extracts greatly induced the expression of proto-oncogenes 
c-fos, c-jun and c-myc in mouse liver, kidney and testis, making it a possible mechanism for MC tumor-promoting activity. 
Recently Fan et al. [88] suggested that hepatic tumorigenesis may also be related with MC-LR stimulation of proto-oncogene c-
myc transcription and the inhibition of protein phosphatase PP2A activity, which has a stabilization effect on c-myc protein, by 
altering the phosphorylation status of serine 62. The higher susceptibility of liver to MCs may be in part related with the OATP 
transport system highly abundant in hepatocytes thereby favoring the uptake of the molecule and its tumor promotion activity. 
The tumorigenic action of MC-LR was suggested to be also under the regulation of the transcription factor NF-κB, and the 
subsequent induction of the expression of interferon alpha (IFN-α) and tumor necrosis factor alpha (TNF-α) [31].  
 
2.8 Global changes in protein expression 
The global gene/protein analysis strategies offer a unique opportunity to report and integrate the multiple molecular events 
occurring in the cells. They are therefore essential strategies to investigate and to disclose the mode of action of environmental 
contaminants such as algal toxins and MCs. In this context a proteomics strategy have led to the observation that MC-RR 
activity in human amniotic epithelial cells (FL) induces several early proteomic alterations related with signal transduction, 
gene transcription and translation, and post-immediate alterations related with cell metabolism, apoptosis, protein degradation, 
cell cycle, cell differentiation, transport functions [89]. Within the differentially expressed proteins Hsp 70 is a known 
determinant of cell death and key regulator of multiple cellular processes. Evidences also confirm the role of p53 and its 
potential targets in MC mediated response and provide first indication that PP2A/A subunit is up-regulated while a number of 
proteins implicated in the ubiquitin-proteasome pathway are down-regulated in cells exposed to MC-RR [89]. The authors 
advance the hypothesis that MCs may modulate PP2A activity through regulation of its expression rather than inhibition of its 
activity directly. 
 
CONCLUSION 
MCs are potent toxins that induce major damages in animal cells through cytotoxic and genotoxic effects leading to apoptosis, 
tumor promotion and cancer as summarized in Figure 1. More recently, it has also been verified that MC is also able to induce 
neurotoxic effects, and provoke damages in reproductive organs. The molecular mechanisms underlying the toxicity of MC 
seems to be a network of causal-effect cascades that are interconnected and lead to a final outcome of damage to the cell and 
apoptosis. The main mechanism of action is possibly triggered by the inhibition of PP2A, which in combination with the 
increase of the intracellular ROS levels induced by MC leads to a series of cellular alterations and damages. In Figure 1 we 
summarize the main so far described effects induced by MCs on animal cells. 
Beyond studying the effect and consequences of exposure to MCs, there have been also some efforts in searching possible ways 
to minimize and remediate the disease effects caused by cyanotoxins. The use of antioxidants such as N-acetylcysteine (NAC), 
buthionine sulfoximine (BSO) and vitamin C can contribute to attenuate the toxic effects induced by MC. Furthermore, 
chemotherapeutical strategies, leading to p53 inactivation, are also a possibility to overcome MCs poisoning [49,90].  
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Figure 1. Proposed pathways of MCs uptake, effects and mechanisms of toxicity, biotransformation and elimination on animal 
cells, to summarize the so far described MC toxicity mechanisms. Legend: CaMKII (calcium calmodulin-dependent 
multifunctional protein kinase II); Ceramide = second messenger; c-fos, c-jun; c-myc (transcription factors); ERK1/2 
(extracellular-signal-regulated kinase); GSH (reduced glutathione); GST (Glutathione S-transferase); JNK (c-Jun N-terminal 
protein kinase); MAPK (Mitogen-activated protein kinase); NF-κB (nuclear factor kappa-light-chain-enhancer of activated B 
cells); OATP (organic anion transporter polypeptide); P (phosphate group); P-gp (P-glycoprotein); PP1/PP2A (protein 
phosphatases PP1 and PP2A); ROS (reactive oxygen species); OH (hydroxyl radical); NO (nitric oxide);  or  refer to 
changes in expression,  refers to inhibition. 
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